Stock info Genetic Technologies Ltd | Filter  Basic-Info

Genetic Technologies Ltd

The core activities of Genetic Technologies Ltd are in the health care eq. & services sector. The global health care companies gained around 102 percent worldwide over the last 10 years. Over the past 5 years the sector is 64 percent higher.

The past year was a relatively good year for Genetic Technologies Ltd investors

The stock lost over the past 12 months at around 62 percent. Over the period 2011-2016 the stock lost a massive -93,68 percent. Genetic Technologies Ltd's revenues between 2011 and 2015 were far from constant and moved between 6,36 million dollars and 1,55 million dollars. Genetic Technologies Ltd's net results between 2011 and 2015 were far from constant and moved between 0,94 million dollars and -6,79 million dollars.

Genetic Technologies Ltd didn't pay out any dividends (in the past 5 years).

Genetic Technologies Ltd financed with lots of debt

At the end of 2015 the American company's balance sheet was worth 15,96 million dollars. At the end of 2015 the total debt positon equaled 1,35 million dollars. This is around 8,46 percent of the total balance sheet. Last year the health care company's price/earnings-ratio (PE) was around -193. So the investors valued the stock at -193 times 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a growth stock.

The health care company's market capitalization (the number of shares outstanding times the market value) equaled around 4,39 billion dollars. At the end of 2015 the American company had around 1,71 billion stocks listed on the stock exchange(s).

All of Genetic Technologies Ltd's annual reports are stored here. More information about Genetic Technologies Ltd can be found it's website. .